varenicline + varenicline
ApprovedCompleted 0 views this week 0 watching⚡ Active
Interest: 43/100
43
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 2✓
Phase 35
ApprovedIndication / Disease
Smoking
Conditions
Smoking
Trial Timeline
Jan 1, 2009 → Feb 1, 2011
NCT ID
NCT00828113About varenicline + varenicline
varenicline + varenicline is a approved stage product being developed by Pfizer for Smoking. The current trial status is completed. This product is registered under clinical trial identifier NCT00828113. Target conditions include Smoking.
What happened to similar drugs?
16 of 20 similar drugs in Smoking were approved
Approved (16) Terminated (0) Active (4)
Hype Score Breakdown
Clinical
20
Activity
8
Company
15
Novelty
0
Community
0
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00828113 | Approved | Completed |
Competing Products
20 competing products in Smoking